Last updated on 2022-07-06

Journal of Clinical Oncology
Research Hotspot & Journal Scope - combination

Homepage · Submit Manuscript · Wikipedia

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.9000

RELAY: A multinational, double-blind, randomized Phase 3 study of erlotinib (ERL) in combination with ramucirumab (RAM) or placebo (PL) in previously untreated patients with epidermal growth factor receptor mutation-positive (EGFRm) metastatic non-small cell lung cancer (NSCLC).

Kazuhiko Nakagawa · Edward B. Garon · Takashi Seto · Makoto Nishio · Santiago Ponce Aix · Chao-Hua Chiu · Keunchil Park · Silvia Novello · Ernest Nadal · Fumio Imamura · Kiyotaka Yoh · Jin-Yuan Shih · Kwok Hung Au · Denis Moro-Sibilot · Sotaro Enatsu · Annamaria Zimmermann · Bente Frimodt-Moller · Carla M. Visseren Grul · Martin Reck ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.2514

A phase I study of ALX148, a CD47 blocker, in combination with established anticancer antibodies in patients with advanced malignancy.

Laura Quan Man Chow · Justin F. Gainor · Nehal J. Lakhani · Hyun Cheol Chung · Keun-Wook Lee · Jeeyun Lee · Patricia LoRusso · Yung-Jue Bang · F. Stephen Hodi · Philip Fanning · Yonggang Zhao · Feng Jin · Hong Wan · Jaume Pons · Sophia Randolph · Wells A. Messersmith ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.7_SUPPL.549

CB-839, a glutaminase inhibitor, in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer (mRCC): Results of a phase I study.

Funda Meric-Bernstam · Richard J. Lee · Bradley Curtis Carthon · Othon Iliopoulos · James W. Mier · Manish R. Patel · Nizar M. Tannir · Taofeek K. Owonikoko · Naomi B. Haas · Martin H. Voss · James J. Harding · Ramaprasad Srinivasan · Geoffrey I. Shapiro · Melinda L. Telli · Pamela N. Munster · Richard D. Carvajal · Yonchu Jenkins · Samuel H. Whiting · Johanna C. Bendell · Todd Michael Bauer ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.8516

Ph1/2 study of Rova-T in combination with nivolumab (Nivo) ± ipilimumab (Ipi) for patients (pts) with 2L+ extensive-stage (ED) SCLC.

Jyoti Malhotra · Petros Nikolinakos · Ticiana Leal · Jonathan M. Lehman · Daniel Morgensztern · Jyoti D. Patel · John Wrangle · Giuseppe Curigliano · Eric Dansin · Laurent Greillier · Melissa L. Johnson · Neal Ready · Gilles Robinet · Satwant Lally · Shekman Wong · Emin Avsar · Ricardo Valenzuela · Charity D. Scripture · Giovanni Selvaggi · Benjamin Besse ·

Medicine
PDF

Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.TPS2669

Phase 1 trial of TLR9 agonist lefitolimod in combination with CTLA-4 checkpoint inhibitor ipilimumab in advanced tumors.

Matthew Reilley · Apostolia Maria Tsimberidou · Sarina Anne Piha-Paul · Timothy A. Yap · Siqing Fu · Aung Naing · Jordi Rodon · Ly M. Nguyen · Casey Ager · Martin Meng · Priyamvada Jayaprakash · Manuel Schmidt · Matthias Baumann · Funda Meric-Bernstam · Michael A. Curran · David S. Hong ·

Medicine
PDF

The objectives of study to determine the addition of synbiotic combinations of Gembili tuber extract and Lactobacillus plantarum in the feed on calcium and protein mass of meat.

Results indicate type and timing of policy combinations as key for successful technology diffusion.

Conclusion The optimized combination of flows could reduce the incidence of thromboembolic events, aortic endothelium stress, and aortic cusps stress/thrombosis.

As the recombination energy of the InAsP/GaAs QDs resides in between the extremes InAs/GaAs and InP/GaAs QDs, these two materials were also analyzed.

This ignores the possible existence of recombination hotspots, and fails to distinguish between coding and non-coding sequences.

Explore More Sentence Examples

Highly Related Keywords from combination

Research Hotspot